BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38888450)

  • 1. Performance of antisaccades in patients with cerebral small vessel disease accompanied by white matter hyperintensities.
    Fan H; Feng J; Ding Y; Gu P; Wang L; Chen X; Geng X
    Neurol Res; 2024 Jun; ():1-8. PubMed ID: 38888450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.
    Wang Y; Liu X; Hu Y; Yu Z; Wu T; Wang J; Liu J; Liu J
    BMC Med Imaging; 2022 Mar; 22(1):40. PubMed ID: 35264145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities combined with serum NLRP3 in diagnosis of cognitive impairment in patients with cerebral small vessel disease.
    Huang R; Zhang L; Deng L; Chen C
    Scand J Clin Lab Invest; 2023 Nov; 83(7):448-454. PubMed ID: 37702579
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood-Brain Barrier Breakdown is a Sensitive Biomarker of Cognitive and Language Impairment in Patients with White Matter Hyperintensities.
    Wang X; Shi Y; Chen Y; Gao Y; Wang T; Li Z; Wang Y
    Neurol Ther; 2023 Oct; 12(5):1745-1758. PubMed ID: 37490234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intensive blood pressure control on cognitive function in patients with cerebral small vessel disease.
    Zhao B; Jia W; Yuan Y; Li Z; Fu X
    J Stroke Cerebrovasc Dis; 2023 Sep; 32(9):107289. PubMed ID: 37544058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Cerebral Small Vessel Disease Burden on MRI Correlates With Medial Temporal Lobe Atrophy and Cognitive Performance in Patients of a Memory Clinic.
    Fan Y; Shen M; Huo Y; Gao X; Li C; Zheng R; Zhang J
    Front Aging Neurosci; 2021; 13():698035. PubMed ID: 34566621
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuity of deep medullary veins in SWI is associated with deep white matter hyperintensity volume and cognitive impairment in cerebral small vessel disease.
    Liao M; Wang M; Li H; Li J; Yi M; Lan L; Ouyang F; Shi L; Fan Y
    J Affect Disord; 2024 Apr; 350():600-607. PubMed ID: 38253134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of white matter hyperintensity volume and total white matter volume for evaluating cognitive impairment in patients with cerebral small-vessel disease.
    Zhang S; Hu Y; Yang H; Li Q; Chen J; Bai H
    Front Aging Neurosci; 2023; 15():1096808. PubMed ID: 37065461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White Matter Imaging Correlates of Early Cognitive Impairment Detected by the Montreal Cognitive Assessment After Transient Ischemic Attack and Minor Stroke.
    Zamboni G; Griffanti L; Jenkinson M; Mazzucco S; Li L; Küker W; Pendlebury ST; Rothwell PM;
    Stroke; 2017 Jun; 48(6):1539-1547. PubMed ID: 28487328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine is Associated with the Development of Cerebral Small Vessel Disease: Retrospective Analyses from Neuroimaging and Cognitive Outcomes.
    Ji Y; Li X; Teng Z; Li X; Jin W; Lv PY
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105393. PubMed ID: 33254368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
    Pasi M; Salvadori E; Poggesi A; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Diciotti S; Mascalchi M; Inzitari D; Pantoni L;
    Stroke; 2015 Jan; 46(1):262-4. PubMed ID: 25395414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM; Zhang MM; Wang YL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
    [No Abstract]   [Full Text] [Related]  

  • 14. U-fiber analysis: a toolbox for automated quantification of U-fibers and white matter hyperintensities.
    Zheng G; Fei B; Ge A; Liu Y; Liu Y; Yang Z; Chen Z; Wang X; Wang H; Ding J
    Quant Imaging Med Surg; 2024 Jan; 14(1):662-683. PubMed ID: 38223048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden.
    Li Y; Li M; Zhang X; Shi Q; Yang S; Fan H; Qin W; Yang L; Yuan J; Jiang T; Hu W
    J Neurol; 2017 Jul; 264(7):1474-1481. PubMed ID: 28653212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlarged Perivascular Spaces Are Negatively Associated With Montreal Cognitive Assessment Scores in Older Adults.
    Libecap TJ; Zachariou V; Bauer CE; Wilcock DM; Jicha GA; Raslau FD; Gold BT
    Front Neurol; 2022; 13():888511. PubMed ID: 35847209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of white matter hyperintensities severity on functional brain activity in cerebral small vessel disease: An rs-fMRI study.
    Hu Y; Yang Y; Hou X; Zhou Y; Nie S
    J Xray Sci Technol; 2022; 30(6):1213-1227. PubMed ID: 36120754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High white matter hyperintensity burden in strategic white matter tracts relates to worse global cognitive performance in community-dwelling individuals.
    Biesbroek JM; Lam BYK; Zhao L; Tang Y; Wang Z; Abrigo J; Chu WWC; Wong A; Shi L; Kuijf HJ; Biessels GJ; Mok VCT
    J Neurol Sci; 2020 Jul; 414():116835. PubMed ID: 32330699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of White Matter Hyperintensity and Cognitive Impairment in Patients with Acute Lacunar Stroke.
    Ye M; Zhou Y; Chen H; Zhu S; Diao S; Zhao J; Kong Y; Li T
    Brain Sci; 2022 Dec; 12(12):. PubMed ID: 36552134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural MRI study of cholinergic pathways and cognition in multiple sclerosis.
    Kimura Y; Sato N; Ota M; Maikusa N; Maekawa T; Sone D; Enokizono M; Sugiyama A; Imabayashi E; Matsuda H; Okamoto T; Yamamura T; Sugimoto H
    eNeurologicalSci; 2017 Sep; 8():11-16. PubMed ID: 29260029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.